Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBJNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EJ.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DQ.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.31.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.1.77NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XAY.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.507NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.178NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.273NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.211NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.474NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.160.14NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.297NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AH.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.280NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.597NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177.45NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177.72NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177.43NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177.85NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.66 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.72 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.133 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.5.1 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.43.7 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.33.1 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XDNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.493NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.351.2 (Beta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.640.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.352NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.251NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HC.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XCJNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FT.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HH.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KN.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.43.1 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.332NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JB.2.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.86.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.12NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JW.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.2.3.18NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBC.1.6.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.39NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.141NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.591NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.468NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used